Ignite Creation Date:
2025-12-24 @ 4:57 PM
Ignite Modification Date:
2026-03-25 @ 8:08 AM
Study NCT ID:
NCT00367250
Status:
UNKNOWN
Last Update Posted:
2010-09-28
First Post:
2006-08-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer
Sponsor:
Medical University of Vienna
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CETRA 01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Medical University Vienna, Austria
Old Organization:
Dept of Internal Medicine I,